Bio-Rad Laboratories Stock (NYSE: BIO) stock price, news, charts, stock research, profile.
Open | $271.38 |
Close | $276.94 |
Volume / Avg. | 193.97K / 247.60K |
Day Range | 270.59 - 277.63 |
52 Wk Range | 261.59 - 431.79 |
Market Cap | $7.90B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NYSE |
RSI | 46 |
Short Interest | 4.86% |
Days to Cover | 4.16 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Bio-Rad Laboratories (NYSE:BIO) through any online brokerage.
Other companies in Bio-Rad Laboratories’s space includes: Medpace Hldgs (NASDAQ:MEDP), Agilent Technologies (NYSE:A), 10x Genomics (NASDAQ:TXG), BioLife Solns (NASDAQ:BLFS) and Waters (NYSE:WAT).
There is no analysis for Bio-Rad Laboratories.
Bio-Rad Laboratories has a consensus price target of $436.67.
The stock price for Bio-Rad Laboratories (NYSE: BIO) is $276.94 last updated July 5, 2024 at 4:00 PM EDT.
A quarterly cash dividend of 0.00 per share of Class A Common Stock. The quarterly cash dividend was payable on Invalid DateTime to stockholders of record on Invalid DateTime.
Bio-Rad Laboratories’s Q2 earnings are confirmed for Thursday, August 1, 2024.
There is no upcoming split for Bio-Rad Laboratories.
Bio-Rad Laboratories is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NYSE.